Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Arcturus Therapeutics Holdings
AddedFeb 20, 2024
UpdatedJun 18, 2026
Arcturus Therapeutics Holdings

Arcturus Therapeutics Holdings

Public

San Diego-based Arcturus Therapeutics Holdings Inc. specializes in RNA therapeutics for disease treatment.

HQ
San Diego, CA, US
Founded
2019
Overview
Compare
Employees
Website

Founded in San Diego, California, Arcturus Therapeutics Holdings Inc. is dedicated to advancing RNA therapeutics for the treatment of various diseases. The company's core mission is to innovate and deliver cutting-edge RNA-based medicines to address unmet medical needs. Their flagship technology, the LUNAR® delivery system, is designed to enhance the delivery and efficacy of RNA therapies. Arcturus Therapeutics primarily focuses on developing treatments for rare genetic disorders, liver diseases, and infectious diseases.

Arcturus Therapeutics has garnered attention from notable investors and industry experts, contributing to its rapid growth and development. The company has achieved significant milestones, including successful preclinical and clinical trials demonstrating the potential of their RNA therapies. Their innovative approach has positioned them as a leader in the RNA therapeutics market, making a substantial impact on the future of disease treatment and patient care.

Arcturus Therapeutics Holdings - Similar Companies

Orbital Therapeutics logo

Orbital Therapeutics

Sirius Therapeutics logo

Sirius Therapeutics

siriusrna.com

Atalanta Therapeutics logo

Atalanta Therapeutics

atalantatx.com

Adarx Pharmaceuticals logo

Adarx Pharmaceuticals

adarx.com

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

arcutis.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Nextrna Therapeutics logo

Nextrna Therapeutics

Regulus Therapeutics logo

Regulus Therapeutics

regulusrx.com

Rnaderm Therapeutics logo

Rnaderm Therapeutics

Silence Therapeutics logo

Silence Therapeutics

Traversa Therapeutics logo

Traversa Therapeutics

traversathera.com

ReNAgade Therapeutics logo

ReNAgade Therapeutics

Locanabio logo

Locanabio

Arcuate Therapeutics logo

Arcuate Therapeutics

Poseida Therapeutics logo

Poseida Therapeutics

poseida.com

Arcturus Therapeutics Holdings - Quick Facts

Who are Arcturus Therapeutics Holdings' competitors?

Companies similar to Arcturus Therapeutics Holdings include Orbital Therapeutics, Sirius Therapeutics, Atalanta Therapeutics and Adarx Pharmaceuticals.

When was Arcturus Therapeutics Holdings founded?

Arcturus Therapeutics Holdings was founded in 2019.

Where is Arcturus Therapeutics Holdings' headquarters located?

Arcturus Therapeutics Holdings' headquarters is located in San Diego, CA, US.

How many employees does Arcturus Therapeutics Holdings have?

Arcturus Therapeutics Holdings has 170 employees as of Feb 6, 2024.

Arcturus Therapeutics Holdings - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • RNA Therapeutics
Tags
  • Biotech
Unique IDs
  • ein: 000000000
  • secCik: 0001768224
  • ticker: ARCT
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research